Clinical Trials Logo

Filter by:
NCT ID: NCT03471104 Withdrawn - Clinical trials for Diabetes Mellitus, Type 1

The Diabetes Patient-Reported Outcome Measures Trial

DiaPROM
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The study aim to evaluate the use of Patient-Reported Outcome Measures in clinical diabetes consultations.

NCT ID: NCT02391922 Withdrawn - Injury Clinical Trials

Better First Aid With First Aid Training and Dispatcher Central Instructions?

Start date: October 2014
Phase: N/A
Study type: Interventional

The study evaluates the effect of a first aid course on first aid skills compared to no training. The study also evaluates the effect of first-aid instructions given by emergency dispatch central over mobile phone on first aid performance to no instructions. Half the participants will perform first aid in two scenarios prior to first aid training. Half the participants will perform first aid in two scenarios 4 to 5 months after attending a first aid course. Half the participants (overall) will receive first aid instructions by mobile phone during the scenarios.

NCT ID: NCT02155842 Withdrawn - Clinical trials for Heart Failure, Diastolic

Exercise Training in Treating Diastolic Heart Failure

TREND-HF
Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether endurance exercise of either high or moderate intensity can reverse structural and functional changes of the heart in patients with diastolic heart failure, and to investigate which type of exercise is best in terms of aerobe capacity and quality of life. The investigators expect that high intensity endurance exercise is superior to moderate intensity endurance exercise.

NCT ID: NCT02048748 Withdrawn - Heart Failure Clinical Trials

Congestive Heart Failure Home Telemonitoring

Start date: February 2014
Phase: N/A
Study type: Interventional

Remote monitoring of chronic heart failure can reduce deaths and hospitalisations, and may provide benefits on health care costs and quality of life. Currently there is limited use of remote monitoring for heart failure in Norway. The funding streams and the structure of the norwegian health service is different from other countries that have tried remote monitoring and therefore it is important to examine the utility of such services in Norway. The study is a randomised controlled trial that will allow participants in the intervention group to use a wireless weight scale and blood pressure monitor device that will send automatically the measurements electronically and securely to the Heart Failure Outpatient Clinic of the hospital.

NCT ID: NCT01997138 Withdrawn - Knee Injuries Clinical Trials

Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy

Start date: March 2016
Phase: Phase 4
Study type: Interventional

This project investigates the relation between acute pain and local inflammation. Pain reported by the patients for knee arthroscopy are compared with local changes in inflammatory mediators by using microdialysis technique. Patients with moderate-to-severe pain are included in a randomized placebo-controlled trial of anakinra given intra-articularly.

NCT ID: NCT01976221 Withdrawn - Communication Clinical Trials

Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom?

Priority
Start date: January 2016
Phase:
Study type: Observational

The referral letter is used for different purposes: a request for a special diagnostic assessment or medical treatment that the GP cannot perform for the patient, an invitation to have a second opinion about a clinical problem or a wish for mutual responsibility for the medical handling. The individual referral rate between GPs varies greatly, and is an important determinant of secondary care utilization. We wanted to study the various elements and factors having an impact on the referral process, from the moment the GP decides to refer the patient until the hospital consultant assess the referral and prioritise the patient for further investigation or treatment. How and why are we, the GPs who refer, so different? We wanted to 1. identify and describe general practitioners' reflections on and attitudes to the referral process and cooperation with hospital specialists 2. identify and describe hospital consultants' reflections on and attitudes to the referral process and cooperation with general practitioners 3. identify typologies characterising GPs in the referral practice

NCT ID: NCT01973504 Withdrawn - Trauma Clinical Trials

Phase 2c Dose Comparison Study of MP4OX in Trauma

Start date: December 2013
Phase: Phase 2
Study type: Interventional

MP4OX is being developed as an ischemic rescue therapy to perfuse and oxygenate tissues at risk during hemorrhagic shock. MP4OX is a pegylated hemoglobin-based colloid designed to improve perfusion and target delivery of oxygen to ischemic tissues. This study will evaluate safety and efficacy of MP4OX treatment, in addition to standard therapy, in trauma patients suffering from lactic acidosis due to severe hemorrhagic shock.

NCT ID: NCT01951911 Withdrawn - Pain, Intractable Clinical Trials

Effectiveness of Ketamine in Malignant Neuropathic Pain Relief

KETA-1
Start date: September 2013
Phase: Phase 3
Study type: Interventional

To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with neuropathic cancer pain.

NCT ID: NCT01913249 Withdrawn - Anorectal Fistula Clinical Trials

Effect of Short Term Versus Long Term Treatment With Seton Prior to LIFT Surgery for Complex Anal Fistula

Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of this study is to compare short term (3 week) with long term (6 months) treatment with seton prior to LIFT surgery. The main end-points are recurrence rates and complication rates after surgery.

NCT ID: NCT01892644 Withdrawn - Clinical trials for Myelodysplastic Syndromes

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

DefeHEMY
Start date: May 2013
Phase: Phase 2
Study type: Interventional

Hypothesis: Deferasirox can be used as a therapeutic agent to deplete the liver, heart and bone marrow of excess iron in patients with iron overload caused by myelodysplastic syndrome (MDS) and hemochromatosis (HC. Assess the effect of new serum biomarkers (NTBI and hepcidin) and MRI as indicators of iron overload and their usefulness to monitor iron depletion treatment. Study the effect of iron overload and iron depletion on intracellular signal transduction, trace metals concentrations in serum and urine and markers of oxidative stress in blood cells and urine.